Similar content being viewed by others Introduction Management of type 2 diabetes mellitus (T2D) remains a major challenge worldwide [1, 2], requiring a multifactorial approach to reduce cardiovascular risk and prevent and address metabolic comorbidities [3, 4]
Essential molecule for supporting healthy brain function
Who Should Consider GLP-1 Drugs And Who Shouldn't Good Candidates BMI 30+ (obese) The primary indication for all weight-management GLP-1s BMI 27+ with a weight-related condition (diabetes, high blood pressure, sleep apnea, PCOS, fatty liver) Failed sustained weight loss through diet and exercise alone for 6+ months Pre-diabetic GLP-1s can prevent progression to Type 2 diabetes Cardiovascular risk Semaglutide specifically has proven heart protection Not Appropriate For Cosmetic weight loss of a few kilograms These are serious medications, not diet pills History of medullary thyroid cancer or MEN2 syndrome Absolute contraindication History of pancreatitis Relative contraindication
CARIM School for Cardiovascular Diseases, Department of Internal Medicine, Maastricht University Medical Center+, Maastricht, Netherlands
Treatment discontinuation was assumed for patients not responding to treatment (i.e
This will disappear after opening
